Stay updated on TEPEZZA Post-Marketing Requirement Study Clinical Trial
Sign up to get notified when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.
Latest updates to the TEPEZZA Post-Marketing Requirement Study Clinical Trial page
- Check2 days agoChange DetectedFooter now displays Revision: v3.3.4, replacing the previous v3.3.3; the remainder of the page content remains unchanged.SummaryDifference0.0%
- Check9 days agoChange DetectedAdded EU CTIS number 2024-515090-96-00 and updated site listings to include Hôpital Claude Huriez-Lille-Rue Michel Polonovski while removing Washington University in St. Louis, Missouri, and the number of locations is listed as 28.SummaryDifference0.5%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations section updated to include new site entries across the US and Europe (e.g., California, Colorado, London, Doubs, Rhône, Lombardy, Campania, Córdoba). Revision: v3.3.3.SummaryDifference2%
- Check52 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. No content or structural changes are visible.SummaryDifference0.0%
- Check60 days agoChange DetectedThe page no longer displays the government funding operating status notice; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check74 days agoChange DetectedThe screenshots show only minor formatting updates with no changes to the study details, endpoints, eligibility, enrollment, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to TEPEZZA Post-Marketing Requirement Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.